Table of Contents 2
List of Tables 5
List of Figures 5
SK Biopharmaceuticals Co., Ltd. Spshot 6
SK Biopharmaceuticals Co., Ltd. Overview 6
Key Information 6
Key Facts 6
SK Biopharmaceuticals Co., Ltd. - Research and Development Overview 7
Key Therapeutic Areas 7
SK Biopharmaceuticals Co., Ltd. - Pipeline Review 10
Pipeline Products by Stage of Development 10
Pipeline Products - Monotherapy 11
SK Biopharmaceuticals Co., Ltd. - Pipeline Products Glance 12
SK Biopharmaceuticals Co., Ltd. - Late Stage Pipeline Products 12
Phase III Products/Combition Treatment Modalities 12
SK Biopharmaceuticals Co., Ltd. - Clinical Stage Pipeline Products 13
Phase II Products/Combition Treatment Modalities 13
Phase I Products/Combition Treatment Modalities 14
SK Biopharmaceuticals Co., Ltd. - Early Stage Pipeline Products 15
IND/CTA Filed Products/Combition Treatment Modalities 15
Preclinical Products/Combition Treatment Modalities 16
Discovery Products/Combition Treatment Modalities 17
SK Biopharmaceuticals Co., Ltd. - Drug Profiles 18
SKL-N05 18
Product Description 18
Mechanism of Action 18
R&D Progress 18
YKP-3089 20
Product Description 20
Mechanism of Action 20
R&D Progress 20
relenopride hydrochloride 22
Product Description 22
Mechanism of Action 22
R&D Progress 22
carisbamate 23
Product Description 23
Mechanism of Action 23
R&D Progress 23
SKL-15508 25
Product Description 25
Mechanism of Action 25
R&D Progress 25
SKL-A4R 26
Product Description 26
Mechanism of Action 26
R&D Progress 26
SKL-PD 27
Product Description 27
Mechanism of Action 27
R&D Progress 27
SKL-PSY 28
Product Description 28
Mechanism of Action 28
R&D Progress 28
N-2 29
Product Description 29
Mechanism of Action 29
R&D Progress 29
SKL-16036 30
Product Description 30
Mechanism of Action 30
R&D Progress 30
SKL-DEP 31
Product Description 31
Mechanism of Action 31
R&D Progress 31
SKL-G 32
Product Description 32
Mechanism of Action 32
R&D Progress 32
Small Molecule for Multiple Sclerosis 33
Product Description 33
Mechanism of Action 33
R&D Progress 33
Small Molecule for Neuropathic Pain 34
Product Description 34
Mechanism of Action 34
R&D Progress 34
Small Molecule for Tauopathies and Alzheimer’s Disease 35
Product Description 35
Mechanism of Action 35
R&D Progress 35
Small Molecule to Inhibit TDP-43 for Amyotrophic Lateral Sclerosis 36
Product Description 36
Mechanism of Action 36
R&D Progress 36
SK Biopharmaceuticals Co., Ltd. - Pipeline Alysis 37
SK Biopharmaceuticals Co., Ltd. - Pipeline Products by Target 37
SK Biopharmaceuticals Co., Ltd. - Pipeline Products by Route of Administration 39
SK Biopharmaceuticals Co., Ltd. - Pipeline Products by Molecule Type 40
SK Biopharmaceuticals Co., Ltd. - Pipeline Products by Mechanism of Action 41
SK Biopharmaceuticals Co., Ltd. - Recent Pipeline Updates 42
SK Biopharmaceuticals Co., Ltd. - Dormant Projects 45
SK Biopharmaceuticals Co., Ltd. - Discontinued Pipeline Products 46
Discontinued Pipeline Product Profiles 46
carisbamate 46
SK Biopharmaceuticals Co., Ltd. - Locations And Subsidiaries 47
Head Office 47
Other Locations & Subsidiaries 47
Appendix 48
Methodology 48
Coverage 48
Secondary Research 48
Primary Research 48
Expert Panel Validation 48
Contact Us 48
Disclaimer 49